DR. JANICE BLUMENTHAL SCHWARTZ, M.D.
Osteopathic Medicine at Silver Ave, San Francisco, CA
License number
California C-36847
Category
Osteopathic Medicine
Type
Cardiovascular Disease
License number
California C-36847
Category
Osteopathic Medicine
Type
Geriatric Medicine
Address
Address
302 Silver Ave DEPARTMENT RESEARCH, San Francisco, CA 94112
Phone
(415) 406-1573
(415) 406-1577 (Fax)
(415) 406-1577 (Fax)
Professional information
Professor/Director, Research At Ucsf/Jewish Home
Position:
Professor/Director, Research at UCSF/Jewish Home
Location:
San Francisco Bay Area
Industry:
Research
Work:
UCSF/Jewish Home
-
Professor/Director, Research
Janice Blumenthal Schwartz, San Francisco CA
Specialties:
Internal Medicine, Cardiovascular Disease, Geriatric Medicine
Work:
Jewish Home For The Aged
302 Silver Ave, San Francisco, CA 94112
302 Silver Ave, San Francisco, CA 94112
Education:
Tulane University (1974)
Medical Information Patch
US Patent:
2005019, Sep 8, 2005
Filed:
Feb 25, 2005
Appl. No.:
11/067096
Inventors:
Janice Schwartz - San Francisco CA, US
International Classification:
G09F003/10
US Classification:
040638000
Abstract:
A medical information patch is provided, which comprises a substrate having a first surface printable with medical information and a second surface comprising an adhesive for adhering the patch to the skin of a person. The substrate is formed of materials that are suitable for printing with any indicia or text conveying medical information. The medical information patch may comprise an emergency supply of a medicament, or a memory chip with personal medical information data stored therein, or a monitor device monitoring user's medical conditions.
Compositions And Methods For Lowering Serum Cholesterol
US Patent:
2009016, Jun 25, 2009
Filed:
Nov 19, 2008
Appl. No.:
12/274189
Inventors:
Janice B. SCHWARTZ - San Francisco CA, US
International Classification:
A61K 31/59
US Classification:
514167
Abstract:
The invention provides a method for lowering circulating LDL-cholesterol or total cholesterol in a human in need thereof, comprising: orally administering to the human a therapeutically effective amount of a statin and vitamin D daily for at least about 6 weeks, wherein the vitamin D is administered by one or more pharmaceutical compositions.